US Supplement Industry Growth Robust, But Stronger With Regulatory Help– NBJ Founder

 
• By Malcolm Spicer

Businesses offering products with undisclosed drugs or labeled with violative claims and the absence of a federal regulation on lawful use of hemp ingredients in supplements are impediments to growth, says Thomas Aarts, NBJ founder currently managing director of Nutrition Business Advisors.

US supplement sales growth normalized to around 7.9% in 2021 after a 14.5% jump in 2020, the first year of the COVID-19 pandemic, and slipping to 7.5% in 2021, according to Nutrition Business Journal data. • Source: NBJ

More from Regulation

More from Policy & Regulation